Mile Janevski Joint 2016 COSA and ANZBCTG Annual Scientific Meeting

Abstracts this author is presenting:

• Subtype-specific activity in liposarcoma (LPS) patients (pts) from a phase 3, open-label, randomized study of eribulin (ERI) versus dacarbazine (DTIC) in pts with advanced LPS and leiomyosarcoma (LMS). — Poster Session 1